Amoxicillin and cotrimoxazole-driven dysbiosis disrupted blood cell levels, cytokine balance and induced oxido-nitrosative stress in young mice

Amoxicillin and cotrimoxazole are among the most frequently prescribed antibiotics, yet their impact on gut microbiota and systemic physiology, particularly during early life, remains a critical concern. This study investigated the effects of these antibiotics on the gut microbiome and associated physiological and biochemical responses in young male Swiss mice (5 weeks old), serving as a model for infant exposure. Five experimental groups were employed: control, amoxicillin (9.62 mg/kg), cotrimoxazole (15 mg/kg), cotrimoxazole + amoxicillin, and cotrimoxazole + amoxicillin followed by probiotic administration. Parameters assessed included gut microbial composition, hematological indices, organ weights, liver and kidney function, cytokine profiles, oxidative stress markers, and histopathological alterations. Both antibiotics induced marked gut dysbiosis. Cotrimoxazole significantly increased leukocyte, neutrophil, lymphocyte, and monocyte counts, while amoxicillin caused thrombocytosis and cotrimoxazole induced thrombocytopenia; probiotic treatment normalized these effects. Amoxicillin reduced brain glutathione (GSH) levels, whereas cotrimoxazole decreased GSH in both liver and brain. Combined antibiotic exposure exacerbated GSH depletion and elevated nitric oxide (NO) and malondialdehyde (MDA) levels, effects mitigated by probiotics exposure. Co-exposure to cotrimoxazole and amoxicillin upregulated pro-inflammatory cytokines TNF-α and IFN-γ and increased serum markers of hepatic and renal injury (alanine-transaminases, alkaline phosphatases, Aspartate transaminases, creatinine, urea, uric acid). Histopathological analysis confirmed aggravated hepatic and renal damage under combined antibiotic exposure, which was markedly alleviated by probiotics. These findings demonstrate that amoxicillin and cotrimoxazole disrupt gut microbial balance, eliciting systemic oxidative, organ damage and inflammatory responses. Probiotic intervention confers significant protection, underscoring the need for cautious antibiotic use and microbiota-restorative strategies.

Authors

Institutions

Publication Details

Journal
Advances in Biomarker Sciences and Technology
Published
2025-11-20
DOI
https://doi.org/10.1016/j.abst.2025.11.002
Citations
1
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Amoxicillin and cotrimoxazole-driven dysbiosis disrupted blood cell levels, cytokine balance and induced oxido-nitrosative stress in young mice

James Nyabuga Nyariki, Silas Kiruki, J Mose, Grace K. Nyambati et al.
1 citations
Advances in Biomarker Sciences and Technology
Gut microbiota and health
0.81
article

Amoxicillin and cotrimoxazole-driven dysbiosis disrupted blood cell levels, cytokine balance and induced oxido-nitrosative stress in young mice

James Nyabuga Nyariki, Silas Kiruki, J Mose, Grace K. Nyambati, Alfred Orina Isaac, Olivia Adhiambo Njiri, O Olatoye Isaac, Kiptoo K. Cosmas
article en
1 citations

Abstract

Amoxicillin and cotrimoxazole are among the most frequently prescribed antibiotics, yet their impact on gut microbiota and systemic physiology, particularly during early life, remains a critical concern. This study investigated the effects of these antibiotics on the gut microbiome and associated physiological and biochemical responses in young male Swiss mice (5 weeks old), serving as a model for infant exposure. Five experimental groups were employed: control, amoxicillin (9.62 mg/kg), cotrimoxazole (15 mg/kg), cotrimoxazole + amoxicillin, and cotrimoxazole + amoxicillin followed by probiotic administration. Parameters assessed included gut microbial composition, hematological indices, organ weights, liver and kidney function, cytokine profiles, oxidative stress markers, and histopathological alterations. Both antibiotics induced marked gut dysbiosis. Cotrimoxazole significantly increased leukocyte, neutrophil, lymphocyte, and monocyte counts, while amoxicillin caused thrombocytosis and cotrimoxazole induced thrombocytopenia; probiotic treatment normalized these effects. Amoxicillin reduced brain glutathione (GSH) levels, whereas cotrimoxazole decreased GSH in both liver and brain. Combined antibiotic exposure exacerbated GSH depletion and elevated nitric oxide (NO) and malondialdehyde (MDA) levels, effects mitigated by probiotics exposure. Co-exposure to cotrimoxazole and amoxicillin upregulated pro-inflammatory cytokines TNF-α and IFN-γ and increased serum markers of hepatic and renal injury (alanine-transaminases, alkaline phosphatases, Aspartate transaminases, creatinine, urea, uric acid). Histopathological analysis confirmed aggravated hepatic and renal damage under combined antibiotic exposure, which was markedly alleviated by probiotics. These findings demonstrate that amoxicillin and cotrimoxazole disrupt gut microbial balance, eliciting systemic oxidative, organ damage and inflammatory responses. Probiotic intervention confers significant protection, underscoring the need for cautious antibiotic use and microbiota-restorative strategies.

Advances in Biomarker Sciences and TechnologyVol. 8
Technical University of Kenya (KE), Meru University of Science and Technology (KE), Chuka University (KE)
Openalex Percentile: Top 21%
Gut microbiota and health
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.